EMD Millipore Expands Bioavailability Enhancement Capabilities

July 19, 2013
LCGC Europe eNews

Volume 0, Issue 0

EMD Millipore, the life science division of Merck KGaA (Darmstadt, Germany), has announced the opening of a new Research & Development Center for Formulation in Darmstadt, Germany. The center is made up of formulation, analytical, and synthetic laboratories with a customer-training center.

EMD Millipore, the life science division of Merck KGaA (Darmstadt, Germany), has announced the opening of a new Research & Development Center for Formulation in Darmstadt, Germany. The center is made up of formulation, analytical, and synthetic laboratories with a customer-training center.

The center has been established to expand EMD Millipore capabilities for the enhancement of bioavailability to meet the needs of pharmaceutical analysis, according to Burghard Freiberg, senior VP, pharma chemicals solutions.

Freiberg said: "There is a clear market need for a comprehensive set of innovative products and technologies to support bioavailability enhancement. At our new center for formulation, we can help customers overcome formulation-related challenges, such as insufficient API performance due to poor solubility and life cycle management developments, in a more effective and efficient manner."

For more information please visit: